Backtester logo
The tape

Takeda Pharmaceutical Co Ltd

TAK

CIK 0001395064 · last filing Jul 6, 2026

Insider signal

trades dated in the last 90 days · non-derivative only

648,756 bought / 0 sold

net +648,756 sh

buys
25
sells
0
insiders active
24

Filing tape

Filed Mon, Jul 6, 2026

  • Gillis StevenDirector

    +3,800 sh
    • Granted3,800Ordinary Shares
    • Returned to company1,152Tax Obligation Award@ $4,931.20
    • Granted1,319Tax Obligation Award
  • Maraganore JohnDirector

    +3,800 sh
    • Granted3,800Ordinary Shares
    • Returned to company1,152Tax Obligation Award@ $4,931.20
    • Granted1,319Tax Obligation Award
  • Reed Kimberly A.Director

    +3,800 sh
    • Granted3,800Ordinary Shares
    • Returned to company1,152Tax Obligation Award@ $4,931.20
    • Granted1,319Tax Obligation Award
  • Iijima MasamiDirector

    +1,800 sh
    • Granted1,800Ordinary Shares
    • Returned to company2,152Tax Obligation Award@ $4,931.20
    • Granted1,937Tax Obligation Award
  • Broussard Bruce DDirector

    +3,800 sh
    • Granted3,800American Depositary Shares
    • Granted1,319Tax Obligation Award
  • Stoffels PaulusDirector

    +3,800 sh
    • Granted3,800Ordinary Shares
    • Granted1,307Tax Obligation Award
  • Kimura KoichiroDirector

    +1,800 sh
    • Granted1,800Ordinary Shares
    • Granted1,937Tax Obligation Award
  • Tsusaka MikiDirector

    +1,800 sh
    • Granted1,800Ordinary Shares
    • Returned to company2,152Tax Obligation Award@ $4,931.20
    • Granted1,937Tax Obligation Award
  • Miyabashira AsukaPresident, Japan Pharma B.U.

    +1,500 sh
    • Granted1,500Ordinary Shares
    • Returned to company1,022Tax Obligation Award@ $4,931.40
    • Granted664Tax Obligation Award
    • Granted664Tax Obligation Award
    • Granted666Tax Obligation Award
  • Furuta MilanoChief Financial Officer · Director

    +12,300 sh
    • Granted12,300Ordinary Shares
    • Returned to company16,619Tax Obligation Award@ $4,931.50
    • Granted4,288Tax Obligation Award
    • Granted4,288Tax Obligation Award
    • Granted4,288Tax Obligation Award
  • Platford Giles RichardPresident, IBU

    +49,558 sh
    • Granted49,558American Depositary Shares
  • Smoter Jennifer MarieChief Comm. & Gov. Officer

    +18,808 sh
    • Granted18,808American Depositary Shares
  • Ibrahim Ramy Riad AhmedPresident, PDT BU

    +25,078 sh
    • Granted25,078American Depositary Shares
  • Greenway Nicola Deidre PetalChief Human Resources Officer

    +22,570 sh
    • Granted22,570American Depositary Shares
  • Farajallah Awny Samaan BotrosChief Medical Officer

    +17,554 sh
    • Granted17,554American Depositary Shares
  • Furney Natalie Anne MarieGlobal General Counsel

    +43,886 sh
    • Granted43,886American Depositary Shares
  • Pacheco Rhonda JanicePresident, U.S. Business Unit

    +50,156 sh
    • Granted50,156American Depositary Shares
  • Pignagnoli Agosti MarcelloHead, Strat. & Port. Dev.

    +27,586 sh
    • Granted27,586American Depositary Shares
  • Ricci GabrieleChief Data & Tech. Officer

    +37,616 sh
    • Granted37,616American Depositary Shares
  • Shannon Elaine MaryPres., Global Supply & Quality

    +30,094 sh
    • Granted30,094American Depositary Shares
  • Duprey Lauren RusckowskiChief Transformation Officer

    +45,140 sh
    • Granted45,140American Depositary Shares
  • Bitetti Teresa MariePresident, OBU

    +43,886 sh
    • Granted43,886American Depositary Shares
  • Kim Julie So-YoungPresident and CEO · Director

    +73,234 sh
    • Granted50,434American Depositary Shares
    • Granted22,800Ordinary Shares
    • Granted7,741Tax Obligation Award
    • Granted7,741Tax Obligation Award
    • Granted7,743Tax Obligation Award
  • Plump Andrew StewartPresident, R&D · Director

    +125,390 sh
    • Granted125,390American Depositary Shares

Insiders on this tape

Informational data only — not investment advice.

The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.

All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.

BDPO Logo

The unified workspace for systematic trading teams. Model data, build indicators, and execute strategies with precision.

© 2026 BDPO. All rights reserved.

BDPO Ltd is not authorised or regulated by the Financial Conduct Authority. The information and data provided on this site are for general informational purposes only and do not constitute financial, investment, or trading advice. Backtested and simulated results are hypothetical, may contain errors, and are not indicative of future performance. Do not rely on any data without independently verifying it.

Takeda Pharmaceutical Co Ltd Insider Trading — Form 4 Buys & Sells | BDPO